356 related articles for article (PubMed ID: 10534351)
1. Characterization of the reactivity pattern of murine monoclonal antibodies against wild-type hepatitis B surface antigen to G145R and other naturally occurring "a" loop escape mutations.
Cooreman MP; van Roosmalen MH; te Morsche R; Sünnen CM; de Ven EM; Jansen JB; Tytgat GN; de Wit PL; Paulij WP
Hepatology; 1999 Nov; 30(5):1287-92. PubMed ID: 10534351
[TBL] [Abstract][Full Text] [Related]
2. Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity.
Zheng X; Weinberger KM; Gehrke R; Isogawa M; Hilken G; Kemper T; Xu Y; Yang D; Jilg W; Roggendorf M; Lu M
Virology; 2004 Nov; 329(2):454-64. PubMed ID: 15518823
[TBL] [Abstract][Full Text] [Related]
3. The amino Acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen.
Tian Y; Xu Y; Zhang Z; Meng Z; Qin L; Lu M; Yang D
J Clin Microbiol; 2007 Sep; 45(9):2971-8. PubMed ID: 17609325
[TBL] [Abstract][Full Text] [Related]
4. [Preparation of anti HBs monoclonal antibody and its combination characterization to both wild-type HBsAg and immune escape mutant HBsAg].
Li FH; Zhang XY; Yan B; Zhang B; Huang YG; Zhang CY; Gong JS; Chen Y; Liu JH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jun; 24(6):594-6. PubMed ID: 18538091
[TBL] [Abstract][Full Text] [Related]
5. Mutated epitopes of hepatitis B surface antigen fused to the core antigen of the virus induce antibodies that react with the native surface antigen.
Shiau AL; Murray K
J Med Virol; 1997 Mar; 51(3):159-66. PubMed ID: 9139078
[TBL] [Abstract][Full Text] [Related]
6. Construction and expression of hepatitis B surface antigen escape variants within the "a" determinant by site directed mutagenesis.
Golsaz Shirazi F; Amiri MM; Mohammadi H; Bayat AA; Roohi A; Khoshnoodi J; Zarnani AH; Jeddi-Tehrani M; Kardar GA; Shokri F
Iran J Immunol; 2013 Sep; 10(3):127-38. PubMed ID: 24076590
[TBL] [Abstract][Full Text] [Related]
7. Infections by hepatitis B surface antigen gene mutants in Europe and North America.
Tabor E
J Med Virol; 2006; 78 Suppl 1():S43-7. PubMed ID: 16622882
[TBL] [Abstract][Full Text] [Related]
8. Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy.
Torresi J; Earnest-Silveira L; Deliyannis G; Edgtton K; Zhuang H; Locarnini SA; Fyfe J; Sozzi T; Jackson DC
Virology; 2002 Feb; 293(2):305-13. PubMed ID: 11886250
[TBL] [Abstract][Full Text] [Related]
9. Antiviral resistance mutations potentiate hepatitis B virus immune evasion through disruption of its surface antigen a determinant.
Sloan RD; Ijaz S; Moore PL; Harrison TJ; Teo CG; Tedder RS
Antivir Ther; 2008; 13(3):439-47. PubMed ID: 18572757
[TBL] [Abstract][Full Text] [Related]
10. Reduced antigenicity of naturally occurring hepatitis B surface antigen variants with substitutions at the amino acid residue 126.
Qiu S; Zhang J; Tian Y; Yang Y; Huang H; Yang D; Lu M; Xu Y
Intervirology; 2008; 51(6):400-6. PubMed ID: 19258718
[TBL] [Abstract][Full Text] [Related]
11. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M
Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033
[TBL] [Abstract][Full Text] [Related]
12. A novel hepatitis B virus variant S 129 (Gln-->Leu): lack of correlation between antigenicity and immunogenicity.
Wu L; He JW; Yao X; Li HM; Wen YM
J Med Virol; 1999 Dec; 59(4):424-30. PubMed ID: 10534722
[TBL] [Abstract][Full Text] [Related]
13. Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant.
Waters JA; Kennedy M; Voet P; Hauser P; Petre J; Carman W; Thomas HC
J Clin Invest; 1992 Dec; 90(6):2543-7. PubMed ID: 1281839
[TBL] [Abstract][Full Text] [Related]
14. PreS deletion mutations of hepatitis B virus in chronically infected patients with simultaneous seropositivity for hepatitis-B surface antigen and anti-HBS antibodies.
Huang X; Qin Y; Zhang P; Tang G; Shi Q; Xu J; Qi F; Shen Q
J Med Virol; 2010 Jan; 82(1):23-31. PubMed ID: 19950231
[TBL] [Abstract][Full Text] [Related]
15. Variants of two major T cell epitopes within the hepatitis B surface antigen are not recognized by specific T helper cells of vaccinated individuals.
Bauer T; Weinberger K; Jilg W
Hepatology; 2002 Feb; 35(2):455-65. PubMed ID: 11826423
[TBL] [Abstract][Full Text] [Related]
16. [Antigenic analysis of the common recombinant mutant types of HBsAg].
Bai Y; Xia GL; Jia ZY; Cong Y; Wang XL; Guo MZ; Zhan MY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Mar; 17(1):31-4. PubMed ID: 12870014
[TBL] [Abstract][Full Text] [Related]
17. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen.
Cooreman MP; Leroux-Roels G; Paulij WP
J Biomed Sci; 2001; 8(3):237-47. PubMed ID: 11385295
[TBL] [Abstract][Full Text] [Related]
18. Intra-familial evidence of horizontal transmission of hepatitis B virus surface antigen mutant G145R.
Oon CJ; Chen WN; Goo KS; Goh KT
J Infect; 2000 Nov; 41(3):260-4. PubMed ID: 11120616
[TBL] [Abstract][Full Text] [Related]
19. [A comparative characteristic of antigenic properties of recombinant and native hbs-antigens with G145R mutation and evaluation of their immunogenicity].
Konopleva MV; Borisova VN; Sokolova MV; Feldsherova AA; Krymskij MA; Semenenko TA; Suslov AP
Vopr Virusol; 2017; 62(4):179-186. PubMed ID: 29733168
[TBL] [Abstract][Full Text] [Related]
20. Biological significance of amino acid substitutions in hepatitis B surface antigen (HBsAg) for glycosylation, secretion, antigenicity and immunogenicity of HBsAg and hepatitis B virus replication.
Wu C; Zhang X; Tian Y; Song J; Yang D; Roggendorf M; Lu M; Chen X
J Gen Virol; 2010 Feb; 91(Pt 2):483-92. PubMed ID: 19812261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
